The Department of Health and Social Care (DHSC) has today (28/04/2025) confirmed the following list of price concessions for April 2025. Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £4.30 Amiodarone 200mg tablets 28 £1.99 Buprenorphine 8mg sublingual tablets sugar free 7 £9.25 Carbimazole 20mg tablets 100 £2.65 Carbimazole 5mg tablets 100 £4.63 Codeine 15mg/5ml
The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will be kept at £9.90 per prescription item for 2025/26. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or
Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Budesonide 1mg/2ml nebuliser suspension unit dose ampoules Zentiva Pharma UK Ltd 20 unit
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2025. PART IIIA – Professional fees (pharmacy contractors) Contractors should note the English Pharmacy Contractor Single Activity Fee has changed from £1.27 to £1.46. This was
Following the recent rollout of Electronic Prescription Service (EPS) in detained estates (HM Prisons), NHS England has identified an issue where the patient’s nominated pharmacy details are being populated in the ‘Pharmacy Stamp Area’ of paper FP10 prescriptions and EPS tokens generated by prescribers – i.e. even tokens for non-nominated EPS prescriptions. This section would
Funding arrangements for community pharmacies, particularly the processes around delivery of retained margin, are not straightforward and it can be difficult for pharmacy owners to predict the impact of any changes on their businesses. This background briefing from Community Pharmacy England’s Funding Team aims to demystify the processes around the distribution and management of margin
MHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/18 Date issued: 24 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Brilique 90mg tablets (G Pharma Ltd) as G Pharma Ltd have informed the MHRA that there is
As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on prescription switching. In this video, Alisha Khatri and Sarah Welbourne from our Dispensing and Supply Team discuss the topic of prescription switching to explain: What prescription switching is and why FP10 paper prescriptions
The Government is yet to conclude consideration of any increases to prescription charges and NHS prescription pre-payment certificates (PPCs) for 2025/26. Therefore, the current charges will roll over into May 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be
The Department of Health and Social Care (DHSC) has today (22/04/2025) confirmed the following initial list of price concessions for April 2025. Drug Pack size Price concession Alendronic acid 70mg tablets 4 £1.15 Chloramphenicol 1% eye ointment 4 £3.08 Clarithromycin 125mg/5ml oral suspension 70 £6.30 Duloxetine 30mg gastro-resistant capsules 28 £1.99 Duloxetine 60mg gastro-resistant capsules
